vs
Side-by-side financial comparison of Northfield Bancorp, Inc. (NFBK) and Phathom Pharmaceuticals, Inc. (PHAT). Click either name above to swap in a different company.
Phathom Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($57.6M vs $41.3M, roughly 1.4× Northfield Bancorp, Inc.). On growth, Phathom Pharmaceuticals, Inc. posted the faster year-over-year revenue change (94.1% vs 12.7%). Northfield Bancorp, Inc. produced more free cash flow last quarter ($52.5M vs $-167.0M).
Northfield Bancorp, Inc. is a regional bank holding company based in the United States, operating primarily across the U.S. Northeast region. It provides a full range of personal and commercial banking services including deposit accounts, mortgage loans, commercial lending, and wealth management solutions for retail consumers, small to medium-sized businesses and local community clients.
Phathom Pharmaceuticals is a clinical-stage biopharmaceutical firm focused on developing and commercializing innovative therapies for gastrointestinal diseases. Its lead product candidates address acid-related disorders, inflammatory bowel disease, and other GI conditions, serving patients mainly across North America and Europe.
NFBK vs PHAT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $41.3M | $57.6M |
| Net Profit | $-27.4M | — |
| Gross Margin | — | 86.7% |
| Operating Margin | -1263.3% | — |
| Net Margin | -1545.5% | — |
| Revenue YoY | 12.7% | 94.1% |
| Net Profit YoY | -343.6% | 71.6% |
| EPS (diluted) | $-0.68 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $41.3M | $57.6M | ||
| Q3 25 | $39.2M | $49.5M | ||
| Q2 25 | $38.9M | $39.5M | ||
| Q1 25 | $34.8M | $28.5M | ||
| Q4 24 | $36.7M | $29.7M | ||
| Q3 24 | $31.8M | $16.4M | ||
| Q2 24 | $31.5M | $7.3M | ||
| Q1 24 | $31.3M | — |
| Q4 25 | $-27.4M | — | ||
| Q3 25 | $10.8M | $-30.0M | ||
| Q2 25 | $9.6M | $-75.8M | ||
| Q1 25 | $7.9M | $-94.3M | ||
| Q4 24 | $11.3M | — | ||
| Q3 24 | $6.5M | $-85.6M | ||
| Q2 24 | $6.0M | $-91.4M | ||
| Q1 24 | $6.2M | — |
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 87.5% | ||
| Q2 25 | — | 87.2% | ||
| Q1 25 | — | 86.9% | ||
| Q4 24 | — | 87.1% | ||
| Q3 24 | — | 85.6% | ||
| Q2 24 | — | 81.2% | ||
| Q1 24 | — | — |
| Q4 25 | -1263.3% | — | ||
| Q3 25 | 37.7% | -30.8% | ||
| Q2 25 | 35.6% | -151.7% | ||
| Q1 25 | 31.0% | -276.5% | ||
| Q4 24 | 38.0% | — | ||
| Q3 24 | 27.9% | -433.0% | ||
| Q2 24 | 29.1% | -1055.4% | ||
| Q1 24 | 27.2% | — |
| Q4 25 | -1545.5% | — | ||
| Q3 25 | 27.4% | -60.5% | ||
| Q2 25 | 24.6% | -191.9% | ||
| Q1 25 | 22.6% | -330.7% | ||
| Q4 24 | 30.7% | — | ||
| Q3 24 | 20.5% | -523.3% | ||
| Q2 24 | 18.9% | -1248.6% | ||
| Q1 24 | 19.9% | — |
| Q4 25 | $-0.68 | — | ||
| Q3 25 | $0.27 | $-0.41 | ||
| Q2 25 | $0.24 | $-1.05 | ||
| Q1 25 | $0.19 | $-1.31 | ||
| Q4 24 | $0.27 | — | ||
| Q3 24 | $0.16 | $-1.32 | ||
| Q2 24 | $0.14 | $-1.56 | ||
| Q1 24 | $0.15 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $164.0M | $130.0M |
| Total DebtLower is stronger | — | $209.1M |
| Stockholders' EquityBook value | $690.1M | $-438.2M |
| Total Assets | $5.8B | $259.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $164.0M | $130.0M | ||
| Q3 25 | $131.7M | $135.2M | ||
| Q2 25 | $97.6M | $149.6M | ||
| Q1 25 | $101.7M | $212.3M | ||
| Q4 24 | $167.7M | $297.3M | ||
| Q3 24 | $232.9M | $334.7M | ||
| Q2 24 | $153.5M | $276.2M | ||
| Q1 24 | $238.8M | — |
| Q4 25 | — | $209.1M | ||
| Q3 25 | — | $207.1M | ||
| Q2 25 | — | $205.1M | ||
| Q1 25 | — | $203.2M | ||
| Q4 24 | $666.4M | $201.4M | ||
| Q3 24 | — | $175.7M | ||
| Q2 24 | — | $174.4M | ||
| Q1 24 | — | — |
| Q4 25 | $690.1M | $-438.2M | ||
| Q3 25 | $719.6M | $-422.5M | ||
| Q2 25 | $710.3M | $-405.8M | ||
| Q1 25 | $711.1M | $-338.4M | ||
| Q4 24 | $704.7M | $-253.6M | ||
| Q3 24 | $699.6M | $-187.1M | ||
| Q2 24 | $693.0M | $-233.8M | ||
| Q1 24 | $698.4M | — |
| Q4 25 | $5.8B | $259.1M | ||
| Q3 25 | $5.7B | $240.3M | ||
| Q2 25 | $5.7B | $250.2M | ||
| Q1 25 | $5.7B | $294.2M | ||
| Q4 24 | $5.7B | $378.3M | ||
| Q3 24 | $5.7B | $387.0M | ||
| Q2 24 | $5.7B | $319.4M | ||
| Q1 24 | $5.9B | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.95× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $53.7M | $-166.8M |
| Free Cash FlowOCF − Capex | $52.5M | $-167.0M |
| FCF MarginFCF / Revenue | 127.1% | -290.0% |
| Capex IntensityCapex / Revenue | 2.8% | 0.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $89.2M | $-328.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $53.7M | $-166.8M | ||
| Q3 25 | $13.9M | $-14.1M | ||
| Q2 25 | $14.1M | $-62.7M | ||
| Q1 25 | $9.4M | $-84.9M | ||
| Q4 24 | $31.1M | $-266.8M | ||
| Q3 24 | $14.0M | $-63.6M | ||
| Q2 24 | $6.9M | $-70.7M | ||
| Q1 24 | $4.2M | — |
| Q4 25 | $52.5M | $-167.0M | ||
| Q3 25 | $13.6M | $-14.1M | ||
| Q2 25 | $13.9M | $-62.8M | ||
| Q1 25 | $9.2M | $-84.9M | ||
| Q4 24 | $30.0M | $-266.9M | ||
| Q3 24 | $13.7M | $-63.6M | ||
| Q2 24 | $6.7M | $-70.8M | ||
| Q1 24 | $3.8M | — |
| Q4 25 | 127.1% | -290.0% | ||
| Q3 25 | 34.6% | -28.6% | ||
| Q2 25 | 35.7% | -159.0% | ||
| Q1 25 | 26.3% | -297.9% | ||
| Q4 24 | 81.6% | -899.8% | ||
| Q3 24 | 43.2% | -389.0% | ||
| Q2 24 | 21.1% | -966.2% | ||
| Q1 24 | 12.1% | — |
| Q4 25 | 2.8% | 0.4% | ||
| Q3 25 | 0.8% | 0.1% | ||
| Q2 25 | 0.6% | 0.2% | ||
| Q1 25 | 0.7% | 0.1% | ||
| Q4 24 | 3.1% | 0.5% | ||
| Q3 24 | 0.7% | 0.3% | ||
| Q2 24 | 0.8% | 0.6% | ||
| Q1 24 | 1.4% | — |
| Q4 25 | — | — | ||
| Q3 25 | 1.29× | — | ||
| Q2 25 | 1.48× | — | ||
| Q1 25 | 1.20× | — | ||
| Q4 24 | 2.76× | — | ||
| Q3 24 | 2.14× | — | ||
| Q2 24 | 1.16× | — | ||
| Q1 24 | 0.68× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
